PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011
USAID has been funding TBCAP/Ethiopia to provide central level support to the FMOH in the fight against TB for the period April 2008 to December 2010. The interventions supported were:Improving diagnostic capacity for TB and TB/HIV, improving clinical diagnosis of TB, strengthening TB/HIV collaborative activities, improving TB drug management system, improving management of MRD TB, improving Infection Control in TB/HIV and strengthening Community TB and TB/HIV Care. A follow-on to the TBCAP project has been awarded to TBCARE,and the prime partner remains KNCV.
Under the new TBCARE the SOW is more focused and most interventions will occur at the Central Level. The primary focus will be on scaling up the Programatic Management of Drug Resistant TB (PMDT). Ethiopia received the Green Light Committee (GLC) approval to treat an initial cohort of 45 patients (Aug 2008). Patients could not start treatment until the MDR-TB ward at St Peter's Hospital in Addis Ababa was completed and second line drugs could be imported. MDR-TB treatment started in February 2009. Since that time, 117 MDR-TB patients have been enrolled for treatment. However, there are an estimated 5000- 8000 MDR-TB cases in-country and currently only cases in Addis Ababa can be treated. TBCARE will focus on providing coordination and leadership at the central level. It will establish a courier service to transport sputum specimens to ENHRI for culture and DST from the regions to the center until such time as these activities can be done by Regional Labs. The project will procure supplemental second line TB drugs (SLD), ancillary drugs to treat side effects, rennovation of ALERT MDR-TB ward to handle additional MDR cases, and scale up of other MDR TB Treatment centers in the regions.
The project will support laboratory networking for quality assurance (Q/A) of Regional Laboratories involved in USAID supported areas. They will ensure supervision from National level to Regional level, and regional level to peripheral health facilities. TB drug forecasting and quantification, and strengthening the TB drug management and distribution system at the central level will ensure that stockouts of TB drugs will not occur in the regions. Finally the project will assist the STOP TB Partnership Ethiopia to identify areas for operational research and assist government entities to conduct the research. Specific, limited evaluations may also need to be supported.
TBCARE will be providing technical as well as financial assisstance to the Federal Ministry of Health (FMOH) to build its capacity to better manage and coordinate selected components of the National TB Program. TBCARE will be closely working with the TB focal persons at the FMOH , including the TB/HIV and MDR TB focal persons to plan, monitor and evaluate implementation of TB program at national as well as regional level. Special emphasis will be given to assist the Ministry with expansion of MDR-TB control program beyond Addis Ababa to the regions, development of Standard Operating Procedures (SOPs) and implementation manuals. TBCARE will also provide technical assistance to the FMOH in the area of strengthening infection control, national and regional TB diagnostic laboratory services particularly in Q/A and second line anti-TB drugs for MDR-TB. Operational research studies in selected areas will be conducted in conjunction with the STOP TB Partnership. TBCARE will work closely with existing partners to coordinate efforts at national and sub-national level to avoid duplication of efforts.
